Moderna
MRNA
#1188
Rank
C$21.76 B
Marketcap
$56.56
Share price
-0.43%
Change (1 day)
-55.04%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Total assets

Total assets on the balance sheet as of September 2024 : C$22.69 Billion

According to Moderna 's latest financial reports the company's total assets are C$22.69 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Moderna - Total assets on balance sheet (from 2017 to 2024)

Total assets by year

Year Total assets Change
2023-12-31C$24.43 B-30.35%
2022-12-31C$35.08 B11.61%
2021-12-31C$31.43 B236.06%
2020-12-31C$9.35 B350.66%
2019-12-31C$2.07 B-22.33%
2018-12-31C$2.67 B96.03%
2017-12-31C$1.36 B-28.41%
2016-12-31C$1.90 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
C$0.13 B-99.41%๐Ÿ‡บ๐Ÿ‡ธ USA
C$168.76 B 643.73%๐Ÿ‡บ๐Ÿ‡ธ USA
C$10.66 M-99.95%๐Ÿ‡บ๐Ÿ‡ธ USA
C$6.03 B-73.39%๐Ÿ‡บ๐Ÿ‡ธ USA
C$148.65 B 555.09%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
C$1.63 B-92.79%๐Ÿ‡บ๐Ÿ‡ธ USA
C$256.00 B 1,028.18%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA